A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma. (Suspended)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822
